MCHXHIGH SIGNALFINANCIAL10-K

MCHX experienced a sharp revenue decline of 30% alongside deteriorating operating losses and reduced cash position, signaling significant business contraction.

The substantial revenue drop coupled with worsening operating losses suggests fundamental challenges in the company's core business performance. The combination of declining top-line results, increased operating losses, and reduced cash reserves creates a concerning financial trajectory that requires close monitoring of the company's ability to return to growth and profitability.

Comparing 2026-03-26 vs 2025-03-14View on EDGAR →
FINANCIAL ANALYSIS

MCHX's financial performance deteriorated notably with revenue falling 30% to $90.3M while operating losses widened to $5.7M from $4.4M in the prior year. The company's cash position declined to $9.9M from $12.8M, though management substantially increased share buybacks to $10.9M from $5.7M and reduced capital expenditures by over 90% to just $36K. The overall picture reflects a business under pressure, with management appearing to focus on capital allocation and cost management while facing headwinds in core revenue generation.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
-91.6%
$429K→$36K

Capex reduced 91.6% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Share Buybacks
Cash Flow
+91.3%
$5.7M→$10.9M

Share repurchases increased 91.3% — management returning capital, signals confidence in intrinsic value.

Revenue
P&L
-30.3%
$129.5M→$90.3M

Revenue declined 30.3% — significant demand weakness or market share loss warrants investigation.

Operating Income
P&L
-28.7%
-$4.4M→-$5.7M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Operating Cash Flow
Cash Flow
-27.5%
-$1.1M→-$1.4M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Cash & Equivalents
Balance Sheet
-22.1%
$12.8M→$9.9M

Cash decreased 22.1% — monitor burn rate and upcoming capital needs.

R&D Expense
P&L
-21.5%
$12.4M→$9.7M

R&D spending cut 21.5% — could signal cost discipline or concerning reduction in innovation investment.

Current Assets
Balance Sheet
-14.5%
$22.3M→$19.0M

Current assets declined 14.5% — monitor working capital adequacy and short-term liquidity.

Current Liabilities
Balance Sheet
-13%
$9.3M→$8.1M

Current liabilities reduced — improved short-term financial position and working capital health.

LANGUAGE CHANGES
NEW — 2026-03-26
PRIOR — 2025-03-14
ADDED
Marchex harnesses the power of artificial intelligence ( AI ) and conversation intelligence to provide actionable insights derived from prescriptive vertical market data analytics.
Marchex enables organizations across business functions to optimize customer acquisitions and experiences, transforming conversations into meaningful business outcomes.
Our conversational intelligence product offerings primarily include: Marketing Edge .
Overall, Marchex sales engagement technology is recognized as an industry leader.
Key Trends Driving our Industry and Business Understanding calls and/or texts is highly complex.
Conversation intelligence platforms increasingly use more advanced AI models, particularly natural language processing and machine learning, to turn spoken or written conversations, such as customer support calls and chats, into structured, actionable data.
Several AI-driven developments are powering these trends, such as improved speech recognition and language models, generative AI for insight extraction, scalable pattern detection, and other real-time intelligence capabilities.
These trends allow organizations to improve sales performance and customer experience, reduce manual review time and human bias, and make data-driven decisions based on customer interactions.
We believe it's critical for businesses to understand the capabilities of AI-powered understanding of human conversations to transform them from unstructured data into a strategic business asset to make informed decisions from for consumer engagement and satisfaction.
Intellectual Property and Proprietary Rights We maintain a number of patents in the U.S.
REMOVED
Marchex harnesses the power of artificial intelligence ( AI ) and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration.
Marchex enables executive, sales, and marketing teams to optimize customer journey experiences across communications channels.
Through our prescriptive analytics solutions, we enable the alignment of enterprise strategy, empowering businesses to increase revenue through informed decision-making and strategic execution.
We have developed applications that incorporate AI functionality for enterprises that depend on phone calls, texts, and other communication channels to help convert prospects into customers, enabling marketing optimization and insights into customer experiences during the sales and support processes and helping maximize returns.
Our conversational intelligence product offerings are: Marketing Edge .
These new features analyze and generate summaries of consumer-to-business calls, enabling businesses to immediately identify customers who have had exceptionally good and dissatisfied experiences.
The platform received the "AI Excellence Award" in the Generative AI category as part of the 2024 Business Intelligence Group ("BIG") AI Intelligence Awards program.
Spotlight was named Product of the Year in the 2023 BIG Awards for Business.
Overall, Marchex sales engagement technology is recognized as an industry leader, winning the 2023 Conversation DNA - Automation Category from AI Excellence Awards.
Engage was also named "Best AI-Based Solution for Sales by AI Breakthrough in 2023.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →